You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 47 No. 9, September 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  CONTROVERSIES IN NEUROLOGY
 This Article
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Continuing Controversy: Magnesium Sulfate in the Treatment of Eclamptic Seizures

Vladimir Hachinski, MD, DSc (Med)

Arch Neurol. 1990;47(9):1032.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Letters prompted by the initial controversy have sharpened the views of Kaplan et al and broadened their evidence. They argue that phenytoin is an effective anticonvulsant for eclamptic seizures and that magnesium sulfate is not an anticonvulsant at all. Everybody agrees that we need more research and controlled clinical trials. In the meantime, magnesium sulfate's preeminence must continue to be challenged. . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.